Enabling Global Rare Disease Research: Jeeva's Role in Multinational Natural History Studies

Discover how Jeeva supports the POLG Foundation's 14-country natural history study, helping address the complexities of global study coordination, regulatory requirements, and longitudinal data collection for POLG-related mitochondrial diseases.

14-Country Study

Regulatory Coordination

Longitudinal Data Collection

CASE STUDY

POLG Foundation

Enabling Global Rare Disease Research: Jeeva's Role in Multinational Natural History Studies

Jeeva Clinical Trials Inc.

What’s inside this case study?

Building the Foundation for Global Rare Disease Research

Learn how multinational natural history studies can support a deeper understanding of disease progression and inform future clinical development.

Coordinating a study across 14 countries

Managing regulatory requirements across multiple geographies

Supporting longitudinal data collection in an ultra-rare disease population

Establishing a foundation for future clinical trial and therapeutic development

Enabling a scalable, compliant, and globally coordinated natural history study is critical to accelerating research in ultra-rare diseases like POLG. Our collaboration with Jeeva supports this mission by providing the infrastructure needed to generate meaningful global data.

Brian Tseng, MD, PhD, CEO, The POLG Foundation